4.4 Article

Genetic variation of GRIN1 confers vulnerability to methamphetamine-dependent psychosis in a Thai population

Journal

NEUROSCIENCE LETTERS
Volume 551, Issue -, Pages 58-61

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2013.07.017

Keywords

Pharmacogenetics; GRIN1; Methamphetamine; Psychosis; Substance misuse

Categories

Funding

  1. Thailand Research Fund (TRF)
  2. Commission of Higher Education (CHE)
  3. British Council PMI2 collaborative grant
  4. Naresuan University

Ask authors/readers for more resources

GRIN1 is a gene that encodes the N-methyl-D aspartate (NMDA) receptor subunit1 (NR1). Variations of GRIN1 have been identified as a risk factor for schizophrenia and drug dependence, supporting hypotheses of glutamatergic dysfunction in these disorders. Methamphetamine (METH) is a psychostimulant drug which can induce psychotic symptoms reminiscent of those found in schizophrenia; thus GRIN1 is a candidate gene for vulnerability to METH dependence or METH-dependent psychosis. The present study examined two polymorphisms of GRIN1, rs11146020 (G1001C) and rs1126442 (G2108A), in 100 male Thai METH-dependent patients and 103 healthy controls using PCR-RFLP techniques. Neither polymorphism was significantly associated with METH dependence, although rs1126442 was highly significantly associated with METH-dependent psychosis, in which the A allele showed reduced frequency (P<0.00001). The present findings indicate that the rs1126442 of GRIN1 contributes to the genetic vulnerability to psychosis in METH-dependent subjects in the Thai population. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available